The Europe veterinary pharmaceuticals market reached USD 9.52 billion in 2027. Market growth is driven by expanding pharmaceutical manufacturing capacity across Europe and increasing pet ownership. Senior Researcher Deepa Pandey analyzed these trends to develop this report, which provides valuable insights for various stakeholders, including veterinary pharmaceutical manufacturers, animal health companies, private equity firms, distributors, and regulatory and market access teams.